Final preparation for the start of commercialization of an innovative test to assess the risk of Alzheimer’s disease – ALTEST

Development of devices for the application of electromagnetic fields in the therapy and monitoring of patients with brain diseases – EMHANCE

Innovative sources of stem cells for accelerated stroke reversal – SUPERCELL

New therapeutic approach in protecting the brain from stress-induced damage – ANTI-STRESS

Current global crisis with the SARS-CoV-2 pandemic reminded us of what has already been announced: our world is very sensitive and not protected against newly appearing microorganisms, viruses and bacteria. It is estimated that we currently recognize less than 20% of their types, with thousands of species which we still need to discover and of which some present and will present an enormous treat to our health. In addition, viruses evolve fast and new sub-types are appearing every year. It is not impossible that a highly contagious and mortal species of virus could completely destroy our civilization. Because it is clear that one of the crucial priorities of the whole world is to develop innovative methods to fight against microroganisms and methods capable to reduce time needed for every step in drug or vaccine design, screening and production, our company is also developing novel vaccine development systems as well as vaccine adjuvants in order to combat the rising toll of viruses on all aspects of modern society.